Chronic kidney disease in the elderly: is it really a premise for overwhelming renal failure?

Locatelli, F.; Pozzoni, P.
June 2006
Kidney International;Jun2006, Vol. 69 Issue 12, p2118
Academic Journal
Increasingly, the majority of patients being diagnosed as affected by chronic kidney disease (CKD) are elderly. Nonetheless, only a rather small proportion of elderly CKD patients actually progress to end-stage renal disease, whereas many more die before this stage is reached, largely because of cardiovascular disease. This underscores the urgent need for cardiovascular prevention, even more importantly than for renoprotection, among elderly patients with CKD.Kidney International (2006) 69, 2118–2120. doi:10.1038/sj.ki.5001547


Related Articles

  • Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators. Melamed, Michal L.; Plantinga, Laura; Shafi, Tariq; Parekh, Rulan; Meyer, Timothy W.; Hostetter, Thomas H.; Coresh, Josef; Powe, Neil R. // BMC Nephrology;2013, Vol. 14 Issue 1, p1 

    Background: Multiple solutes are retained in uremia, but it is currently unclear which solutes are toxic. Small studies suggest that protein-bound solutes, such as p-cresol sulfate and indoxyl sulfate and intracellular solutes, such as methylamine (MMA) and dimethylamine (DMA), may be toxic. Our...

  • Hyperphosphatemia IN RENAL FAILURE. ROBB, MEIGAN // RN;Dec2008, Vol. 71 Issue 12, p26 

    The article discusses the condition called hyperphosphatemia among patients with end-stage renal disease (ESRD) and highlights the role of nurses in such patients. It mentions that the said condition may lead to renal osteodystrophy, cardiovascular disease and death if effective medical...

  • Strategy to estimate risk progression of chronic kidney disease, cardiovascular risk, and referral to nephrology: the EPIRCE Study. Gayoso-Diz, Pilar; Otero-González, Alfonso; Rodríguez-Álvarez, M. Xosé; García, Fernando; González-Quintela, Arturo; Martín-de Francisco, Ángel L. // Nefrologia;2013, Vol. 33 Issue 2, p223 

    Background: Although the prevalence of chronic kidney disease (CKD) is 10-14%, several prospective studies note a low rate of progression to end-stage renal disease (ESRD) in stages 3 and 4. A correct classification of risk of progression, based on demonstrated predictive factors, would allow...

  • Caution advised in interpreting nonsignificant results from ADVANCE post hoc analysis. Brar, Jyoti E // Kidney International;Sep2013, Vol. 84 Issue 3, p621 

    A letter to the editor is presented in response to the article regarding the post hoc analysis on the number needed to treat (NNT) in preventing one end-stage renal disease (ESRD).

  • Continuing Education Test #1149.  // RN;Dec2008, Vol. 71 Issue 12, p31 

    A quiz concerning hyperphosphatemia amond patients with end-stage renal disease is presented.

  • Noncompliance.  // Nephrology Nursing Journal;Dec2001, Vol. 28 Issue 6, p653 

    Reviews several research regarding noncompliance of patients in their kidney failure regimen. Details on the research; Treatment strategies used to increase compliance; Comments on the studies.

  • A healthy start can slow progression. Lindberg, Jill; Filangeri, Judith // Exceptional Parent;May99, Vol. 29 Issue 5, p72 

    Part IV. Discusses the Healthy Start educational program offered by the Oschner Clinic Renal Services for people with pre-end stage renal disease and their families. Principle behind the program; Types of classes offered; Includes the basic class and the advanced class; Goals; Function of the...

  • Characteristics of South African patients presenting with kidney disease in rural KwaZulu-Natal: a cross sectional study. Madala, Nomandla D.; Thusi, Gertrude P.; Assounga, Alain G. H.; Naicker, Saraladevi // BMC Nephrology;2014, Vol. 15 Issue 1, p1 

    Background Diabetes mellitus is the leading cause of end-stage renal disease (ESRD) globally. Diabetes and human immunodeficiency virus (HIV), both prevalent in South Africa, have not been reported as significant causes of ESRD. Methods We evaluated chronic kidney disease (CKD) and...

  • Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Lau, Wei Ling; Leaf, Elizabeth M; Hu, Ming Chang; Takeno, Marc M; Kuro-o, Makoto; Moe, Orson W; Giachelli, Cecilia M // Kidney International;Dec2012, Vol. 82 Issue 12, p1261 

    Vascular calcification is common in chronic kidney disease, where cardiovascular mortality remains the leading cause of death. Patients with kidney disease are often prescribed vitamin D receptor agonists (VDRAs) that confer a survival benefit, but the underlying mechanisms remain unclear. Here...

  • Suppressed soluble Fms-like tyrosine kinase-1 production aggravates atherosclerosis in chronic kidney disease. Matsui, Masaru; Takeda, Yukiji; Uemura, Shiro; Matsumoto, Takaki; Seno, Ayako; Onoue, Kenji; Tsushima, Hideo; Morimoto, Katsuhiko; Soeda, Tsunenari; Okayama, Satoshi; Somekawa, Satoshi; Samejima, Ken-ichi; Kawata, Hiroyuki; Kawakami, Rika; Nakatani, Kimihiko; Iwano, Masayuki; Saito, Yoshihiko // Kidney International;Feb2014, Vol. 85 Issue 2, p393 

    Patients with chronic kidney disease (CKD) die of cardiovascular diseases for unknown reasons. Blood vessel formation in plaques and its relationship with plaque stability could be involved with signaling through the Flt-1 receptor and its ligands, vascular endothelial growth factor, and the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics